Patients with Cree leukoencephalopathy typically have a disease onset in the second half of the first year of life and are terminal before the age of 2 years.44 That is exactly what is seen in the homozygous p.Arg191His mutant Eif2b5 mouse model. The gene discussed is EIF2B5; the disease is leukoencephalopathy with vanishing white matter.